Scientific excellence is not an end in itself, but is a crucial tool for efficient translation of new ideas into viable solutions.

White S, Laske K, Welters MJ, Bidmon N, van der Burg, Sjoerd H, Britten CM, Enzor J, Staats J, Weinhold KJ, Gouttefangeas C, Chan C. (2014)

Managing Multi-center Flow Cytometry Data for Immune Monitoring.

Cancer informatics 2014, 13:111-122.

Kloke B, Mahr A, Jabulowsky RA, Kutscher S, Rae R, Britten CM. (2014)

Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6-8, 2014.

Cancer immunology, immunotherapy: CII 2015, 64:923-930.

Simon P, Omokoko TA, Breitkreuz A, Hebich L, Kreiter S, Attig S, Konur A, Britten CM, Paret C, Dhaene K, Tureci Ö, Sahin U. (2014)

Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopes.

Cancer Immunology Research 2 (12) (2014) 1230–1244.

Diken M, Boegel S, Grunwitz C, Kranz LM, Reuter K, van de Roemer, Niels, Vascotto F, Vormehr M, Kreiter S. (2014)

CIMT 2014: Next waves in cancer immunotherapy–report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.

Human vaccines & immunotherapeutics 2014, 10:3090-3100.

Boegel S, Löwer M, Bukur T, Sahin U, Castle JC. (2014)

A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.

Oncoimmunology 2014, 3:e954893.

Boisguérin V, Castle JC, Loewer M, Diekmann J, Mueller F, Britten CM, Kreiter S, Türeci Ö, Sahin U. (2014)

Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside.

Br J Cancer 2014, 111:1469-1475.

Hadrup SR, Maurer D, Laske K, Frøsig TM, Andersen SR, Britten CM, van der Burg, Sjoerd H, Walter S, Gouttefangeas C. (2014)

Cryopreservation of MHC multimers: Recommendations for quality assurance in detection of antigen specific T cells.

Cytometry. Part A: the journal of the International Society for Analytical Cytology 2015, 87:37-48.

Sahin U, Kariko K, Tureci O. (2014)

mRNA-based therapeutics–developing a new class of drugs.

Nature Reviews Drug Discovery 13 (10) (2014) 759–780.

Muhammad K, Alrefai H, Marienfeld R, Pham, Duong Anh Thuy, Murti K, Patra AK, Avots A, Bukur V, Sahin U, Kondo E, Klein-Hessling S, Serfling E. (2014)

NF-κB factors control the induction of NFATc1 in B lymphocytes.

European journal of immunology 2014, 44:3392-3402.

Kuehnle M, Attig S, Britten CM, Schulze-Bergkamen H, Lordick F, Wichert G von, Thuss-Patience P, Stein A, Schuler M, Bassermann F, Sahin U, Türeci O. (2014)

Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction.

Cancer immunology, immunotherapy: CII 2014, 63:1273-1284.

Kowalska J, Wypijewska del Nogal, Anna, Darzynkiewicz ZM, Buck J, Nicola C, Kuhn AN, Lukaszewicz M, Zuberek J, Strenkowska M, Ziemniak M, Maciejczyk M, Bojarska E, Rhoads RE, Darzynkiewicz E, Sahin U, Jemielity J. (2014)

Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes.

Nucleic acids research 2014, 42:10245-10264.

Chudley L, McCann KJ, Coleman A, Cazaly AM, Bidmon N, Britten CM, van der Burg, Sjoerd H, Gouttefangeas C, Jandus C, Laske K, Maurer D, Romero P, Schröder H, Stynenbosch, Linda F M, Walter S, Welters, Marij J P, Ottensmeier CH. (2014)

Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8(+) T cells with detection by ELISPOT and HLA-multimer staining.

Cancer immunology, immunotherapy: CII 2014, 63:1199-1211.

Reuter S, Martin H, Beckert H, Bros M, Montermann E, Belz C, Heinz A, Ohngemach S, Sahin U, Stassen M, Buhl R, Eshkind L, Taube C. (2014)

The Wnt/β-catenin pathway attenuates experimental allergic airway disease.

Journal of immunology (Baltimore, Md.: 1950) 2014, 193:485-495.

Schumacher T, Bunse L, Pusch S, Sahm F, Wiestler B, Quandt J, Menn O, Osswald M, Oezen I, Ott M, Keil M, Balß J, Rauschenbach K, Grabowska AK, Vogler I, Diekmann J, Trautwein N, Eichmüller SB, Okun J, Stevanović S, Riemer AB, Sahin U, Friese MA, Beckhove P, Deimling A von, Wick W, Platten M. (2014)

A vaccine targeting mutant IDH1 induces antitumour immunity.

Nature 2014, 512:324-327.

Janetzki S, Britten CM. (2014)

The role of the reporting framework MIATA within current efforts to advance immune monitoring.

Journal of immunological methods 2014, 409:6-8.

Castle JC, Loewer M, Boegel S, Tadmor AD, Boisguerin V, Graaf J de, Paret C, Diken M, Kreiter S, Türeci Ö, Sahin U. (2014)

Mutated tumor alleles are expressed according to their DNA frequency.

Scientific reports 2014, 4:4743.

Koste L, Beissert T, Hoff H, Pretsch L, Türeci Ö, Sahin U. (2014)

T-cell receptor transfer into human T cells with ecotropic retroviral vectors.

Gene Therapy 21 (5) (2014) 533-538.

Micke P, Mattsson, Johanna Sofia Margareta, Edlund K, Lohr M, Jirström K, Berglund A, Botling J, Rahnenfuehrer J, Marincevic M, Pontén F, Ekman S, Hengstler J, Wöll S, Sahin U, Türeci O. (2014)

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.

International journal of cancer. Journal international du cancer 2014, 135:2206-2214.

Castle JC, Loewer M, Boegel S, Graaf J de, Bender C, Tadmor AD, Boisguerin V, Bukur T, Sorn P, Paret C, Diken M, Kreiter S, Türeci Ö, Sahin U. (2014)

Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma.

BMC genomics 2014, 15:190.

Schnatbaum K, Schmoldt H, Daneschdar M, Plum LM, Jansong J, Zerweck J, Kühne Y, Masch A, Wenschuh H, Fiedler M, Türeci Ö, Sahin U, Reimer U. (2014)

Peptide microarrays enable rapid mimotope optimization for pharmacokinetic analysis of the novel therapeutic antibody IMAB362.

Biotechnology journal 2014, 9:545-554.